Mon Oct 06 21:00:00 UTC 2025: Okay, here’s a summary of the text, followed by a rewrite as a news article:

**Summary:**

Oscar Health (OSCR) experienced a significant surge in its share price during Friday’s trading, climbing 8.3%. This increase occurred despite a decrease in trading volume compared to its average. Recent analyst activity has been mixed, with several downgrades from “outperform” or “strong buy” to “hold” or “market perform” and lowered price targets. The company recently reported quarterly earnings, beating EPS estimates slightly but missing revenue expectations. An insider, Mario Schlosser, recently sold a large portion of his shares. Institutional investors have recently adjusted their positions in the stock, some increasing and others decreasing their holdings. The stock currently has a consensus rating of “Strong Sell” and an average price target significantly below its current trading price.

**News Article:**

**Oscar Health Shares Jump Despite Analyst Concerns**

NEW YORK, NY – Shares of Oscar Health, Inc. (NYSE:OSCR) soared 8.3% in Friday’s trading, reaching a high of $21.08 before settling at $20.88 by mid-day. The surge occurred despite a 54% drop in trading volume compared to the average, with approximately 6.46 million shares changing hands.

The stock’s positive movement comes amidst mixed sentiment from Wall Street analysts. Recent reports show several firms downgrading their ratings on OSCR, including Baird R.W., Raymond James Financial, and UBS Group. Price targets have also been lowered by these and other firms like Piper Sandler, contributing to an overall consensus rating of “Strong Sell” and an average price target of just $12.07, according to MarketBeat data.

Oscar Health’s recent quarterly earnings, released on August 6th, revealed a slight beat on earnings per share (EPS) with a reported loss of $0.89 per share, $0.01 better than expected. However, revenue fell slightly short of expectations at $2.86 billion, although it represented a 29% increase year-over-year.

In a notable transaction, insider Mario Schlosser recently sold 395,000 shares of Oscar Health stock at an average price of $18.43, netting over $7.2 million. This sale represents a significant reduction in Schlosser’s holdings.

Institutional investor activity has been diverse. While Thrive Capital Management LLC significantly increased its stake in Oscar Health, others like Wealth Enhancement Advisory Services LLC and California State Teachers Retirement System modestly increased their positions. GAMMA Investing LLC and Rhumbline Advisers also increased their stakes, showing continued interest in the company from some institutional players.

Oscar Health, a health insurance company operating in the US, offers health plans in individual and small group markets, as well as a technology-driven platform, +Oscar, that enables providers and payors to shift to value-based care.

While today’s share price increase offers some positive news for investors, analysts remain cautious, suggesting potential headwinds for the company.

Read More